This Solicitation opportunity from Department Of Defense was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

ARTIFICIAL TEARS SOLUT

Closed

SPE2DP-26-T-4157Federal

Submission Closed07/22/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Pharmaceutical Supply – Amlodipine Besylate TabletsThis subcontract with the Defense Logistics Agency under the Department of Defense involves the supply and delivery of Amlodipine Besylate Tablets. The contractor must ensure all products meet specific NDC and NSN 6505013675244 specifications and maintain full compliance with FDA current Good Manufacturing Practice regulations. The agreement is categorized under NAICS code 325412 for pharmaceutical manufacturing. All shipments are to be handled as FOB destination, and the contract is officially tracked under the award record associated with the Defense Logistics Agency.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Supply of Oseltamivir Phosphate (Tamiflu)This subcontract with the Defense Logistics Agency under the Department of Defense involves the procurement and delivery of 12,000 PG of Oseltamivir Phosphate, commonly known as Tamiflu. The scope of work encompasses the entire supply chain process, including the sourcing of the pharmaceutical, professional packaging, labeling, and final shipment to a designated military logistics facility. Classified under NAICS code 325412, the contract ensures the availability of critical antiviral medication for military use. The agreement is managed through the Defense Logistics Agency and follows specific federal procurement standards for pharmaceutical supply and distribution.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Product Supply – Bupivacaine Hydrochloride InjectionThis subcontract involves the manufacture and supply of Bupivacaine Hydrochloride Injection USP, 0.5%, in 50 mL quantities for the Department of Defense via the Medical Supply Chain Pharm FSA. The products must strictly adhere to FDA cGMP standards and meet specific packaging and labeling requirements, including MIL-STD-129, RP001, and DLA guidelines. The opportunity is categorized under NAICS code 325412. Interested parties must submit their responses by the deadline of August 24, 2026, following the posting date of August 17, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supply – Amlodipine Besylate TabletsThis subcontract involves the manufacture and supply of FDA-compliant generic Amlodipine Besylate Tablets for the Defense Logistics Agency under the Department of Defense. The contractor is required to adhere to current Good Manufacturing Practice standards to ensure the pharmaceutical products are suitable for delivery to a federal medical facility. The agreement is categorized under NAICS code 325412 for pharmaceutical preparation. It was posted on August 17, 2026, and is managed through the Defense Logistics Agency's procurement systems to support medical readiness and healthcare delivery within the federal system.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Product Supply – Diphenhydramine Hydrochloride InjectionThis subcontract, issued by the Defense Logistics Agency under the Department of Defense, involves the supply of one box of Diphenhydramine Hydrochloride Injection, identified by NSN 6505016490647. The product must comply with all applicable federal standards and be delivered to a designated military facility located in San Diego, California. The contract is categorized under NAICS code 325412 for pharmaceutical preparation. It was posted on August 17, 2026, and is managed through the DIBBS system under contract number SPE2DX25D9822.

Defense Logistics Agency

POSTED

DEADLINE

Manufacturing of Hemostatic DressingsThis subcontract involves the full-scale production of sterile hemostatic dressings composed of human fibrinogen, thrombin, and oxidized regenerated cellulose. The manufacturing process must strictly adhere to FDA and DLA standards to ensure medical compliance and safety. The project is managed by the Department of Defense under the Medical Supply Chain MD Surg FSF agency, with the place of performance located at Fort Bragg, ZIP code 28310. The solicitation was posted on August 17, 2026, and requires a response by August 24, 2026, falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Epinephrine Injection (NDC 42023-0159-25)The Defense Logistics Agency, under the Department of Defense, has issued a subcontract for the supply and delivery of Epinephrine Injection. The required product is specified as 1 mg/mL in 30 x 1 mL vials per unit of issue, identified by NDC 42023-0159-25. All deliverables must strictly comply with FDA, DEA, and cGMP standards to ensure pharmaceutical quality and regulatory adherence. This procurement falls under NAICS code 325412 and was posted on August 17, 2026. The contract is managed through the Defense Logistics Agency's procurement systems, focusing on the consistent provision of critical medical supplies for military and governmental use.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Supply – Omeprazole CapsulesThis subcontract involves the supply and delivery of four units of Omeprazole Extended-Release Capsules, 20 mg, for the Department of Defense through the Medical Supply Chain Pharm FSA. The pharmaceutical products must strictly adhere to FDA, DLA, and military medical standards regarding regulatory requirements, labeling, and packaging. The contract is categorized under NAICS code 325412 and is to be performed at Fort Bliss, Texas. Interested parties must submit their responses by August 24, 2026, following the posting date of August 17, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical Reagent Supply – Fluoride Water Sampling Test KitsThis subcontract opportunity with the Department of Defense Medical Supply Chain FSH involves the procurement of FDA-compliant, medical-grade water sampling test reagents specifically designed for fluoride detection. All supplied items must be sealed and shelf-stable, with a strict delivery requirement of 20 days following the receipt of the order. The contract is categorized under NAICS code 325412 and will be performed at Davis Monthan AFB in Arizona. Interested parties must submit their responses by the deadline of August 24, 2026.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Pharmaceutical Supply – Haloperidol Injection and Similar NDC ItemsThis subcontract with the Defense Logistics Agency under the Department of Defense involves the supply of FDA-approved Haloperidol Injection and other specific NDC pharmaceuticals. The scope of work includes the provision of packaging, labeling, and strict adherence to regulatory compliance standards to ensure all items are delivered according to DLA contract requirements. Classified under NAICS code 325412, the agreement focuses on the procurement and delivery of specialized pharmaceutical products. The contract was posted on August 17, 2026, and is managed through the Defense Logistics Agency's procurement systems.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Manufacturing – Sterile Injectable SolutionsThis subcontract opportunity with the Department of Defense, managed by the Medical Supply Chain Pharm FSA, involves the manufacture of sterile Sodium Chloride Injection 0.9%. The required product consists of 100 mL doses provided in 150 mL fill plastic containers, with production must adhere to FDA cGMP, USP 797, and specific military shelf-life standards. The project falls under NAICS code 325412 and is designated for performance at Fort Bragg, ZIP code 28310. Interested parties must submit their responses by the deadline of August 24, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing – Benzonatate CapsulesThis subcontract involves the pharmaceutical manufacturing of 100 mg benzonatate capsules for the Department of Defense, specifically through the Medical Supply Chain Pharm FSA. The contractor is required to produce the medication in 100-count bottles that strictly adhere to FDA compliance, USP standards, and DLA technical requirements. The opportunity was posted on August 17, 2026, with a response deadline of August 24, 2026. Classified under NAICS code 325412, this procurement focuses on the production of pharmaceutical preparations to meet specific military medical supply chain needs.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 5 days

AI Contract Overview

The contract specifies the procurement of an FDA-regulated artificial tears solution in 0.3 mL single-use bottles, packaged at 30 bottles per pack group, with a total requirement of two pack groups. Delivery is required within 20 days after order placement to Fort Stewart, Georgia, under FOB Destination terms, with inspection and acceptance also occurring at the destination. The product must meet a non-extendable shelf-life of 24 months and comply with DLA’s Master List of Technical and Quality Requirements, including packaging standards RP001 and RA001. All packaging and marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and preservation must follow MIL-STD-2073-1E. The item is manufactured by Allergan Inc, identified by part number 004554 and NDC 00023-4554-30. Hazardous materials labeling must comply with OSHA’s Hazard Communication Standard, and radioactive material handling, if applicable, must conform to MIL-STD-129. Proposals must be submitted electronically via the DLA Internet Bid Board System by the deadline of July 22, 2026, and include required representations such as Unique Entity ID and CAGE code, along with socioeconomic certifications if claiming small business status. The contract incorporates multiple FAR and DFARS clauses addressing contract type, equal opportunity, trafficking in persons, employment eligibility, sustainable products, hazardous materials, authorization and consent, whistleblower rights, information disclosure, government work product control, payment levies, cybersecurity requirements per NIST SP 800-171, subcontracts for commercial items, safety issue reporting, and sea transportation rules. Subcontracting and compensation of former DoD officials are governed by applicable DFARS provisions. Payment processing is mandated through Wide Area WorkFlow, and the solicitation allows for small business set-asides under multiple NAICS codes with postaward representation requirements. Technical and quality specifications referenced in the DLA Master List control the procurement, and no pricing details are disclosed in the solicitation, indicating award will be based on responsive and compliant submissions without a disclosed budget ceiling.

General Info

Procure 60 units of 0.3 mL Artificial Tears, FDA-regulated, 24-month shelf life, shipped to Fort Stewart, GA, by July 22, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4157 Medical Supply Chain

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedJul 16

Solicitation

Response DeadlineJul 22

Deadline has passed

Submission Closed

07/22/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressUSA

Contacts

Patrell Postell

contact@example.gov

Full Description

ARTIFICIAL TEARS SOLUTION
ARTIFICIAL TEARS SOLUTION, 0.3 ML, 30S
U/I PG OF 30 BOTTLES
Store at 59-86F 15-30C RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
1 PG = 30 EA
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-4157
SECTION B
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
ALLERGAN INC 24172 P/N 004554 ALLERGAN INC 24172 P/N NDC00023-4554-30
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017505585 0001 PG 2.000
NSN/MATERIAL:6505013187683
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-318-7683 Quantity: 2 PG Purchase Request: 7017505585QTY: 2 Delivery: 20 days ADO